Log in

Relevant bibliographies by topics / Antibacterial agents / Journal articles

To see the other types of publications on this topic, follow the link: Antibacterial agents.

Journal articles on the topic 'Antibacterial agents'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Antibacterial agents.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Bremner, John B. "Some approaches to new antibacterial agents." Pure and Applied Chemistry 79, no. 12 (2007): 2143–53. http://dx.doi.org/10.1351/pac200779122143.

Full text

Abstract:

Bacteria use a number of resistance mechanisms to counter the antibacterial challenge, and one of these is the expression of transmembrane protein-based efflux pumps which can pump out antibacterials from within the cells, thus lowering the antibacterial concentration to nonlethal levels. For example, in S. aureus, the NorA pump can pump out the antibacterial alkaloid berberine and ciprofloxacin. One general strategy to reduce the health threat of resistant bacteria is to block a major bacterial resistance mechanism at the same time as interfering with another bacterial pathway or target site.

APA, Harvard, Vancouver, ISO, and other styles

2

Kaye, Elaine T., and Kenneth M. Kaye. "TOPICAL ANTIBACTERIAL AGENTS." Infectious Disease Clinics of North America 9, no. 3 (1995): 547–59. http://dx.doi.org/10.1016/s0891-5520(20)30685-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Thorsteinsson, T., T. Loftsson, and M. Masson. "Soft Antibacterial Agents." Current Medicinal Chemistry 10, no. 13 (2003): 1129–36. http://dx.doi.org/10.2174/0929867033457520.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Brickner, Steven J. "Oxazolidinone Antibacterial Agents." Current Pharmaceutical Design 2, no. 2 (1996): 175–94. http://dx.doi.org/10.2174/1381612802666220921173820.

Full text

Abstract:

The oxazolidinones are a new class of synthetic antibacterial agents. These compounds demonstrate potent in vitro and in vivo activity against important human pathogens, including multiple antibiotic-resistant strains of gram positive organisms including the staphylococci, streptococci, and enterococci. The oxazolidinones have a novel mechanism of action, inhibiting bacterial protein synthesis at a very early step prior to initiation. Literature disclosures have described the inability to detect in vitro bacterial resistance development to the oxazolidinones. Only the (S)-enantiomer is active;

APA, Harvard, Vancouver, ISO, and other styles

5

Telford, Mark. "Releasing antibacterial agents." Materials Today 7, no. 12 (2004): 10. http://dx.doi.org/10.1016/s1369-7021(04)00613-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hussar, Daniel A. "New Antibacterial Agents." American Pharmacy 33, no. 1 (1993): 41–46. http://dx.doi.org/10.1016/s0160-3450(15)30889-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kaye, Elaine T. "TOPICAL ANTIBACTERIAL AGENTS." Infectious Disease Clinics of North America 14, no. 2 (2000): 321–39. http://dx.doi.org/10.1016/s0891-5520(05)70250-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lio, Peter A., and Elaine T. Kaye. "Topical Antibacterial Agents." Medical Clinics of North America 95, no. 4 (2011): 703–21. http://dx.doi.org/10.1016/j.mcna.2011.03.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lio, Peter A., and Elaine T. Kaye. "Topical antibacterial agents." Infectious Disease Clinics of North America 18, no. 3 (2004): 717–33. http://dx.doi.org/10.1016/j.idc.2004.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lio, Peter A., and Elaine T. Kaye. "Topical Antibacterial Agents." Infectious Disease Clinics of North America 23, no. 4 (2009): 945–63. http://dx.doi.org/10.1016/j.idc.2009.06.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Verma, Tarawanti, and Nitin Bansal. "Triazinone Derivatives as Antibacterial and Antimalarial Agents." Asian Pacific Journal of Health Sciences 6, no. 2 (2019): 1–20. http://dx.doi.org/10.21276/apjhs.2019.6.2.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Korzeniowski, Oksana M. "ANTIBACTERIAL AGENTS IN PREGNANCY." Infectious Disease Clinics of North America 9, no. 3 (1995): 639–51. http://dx.doi.org/10.1016/s0891-5520(20)30690-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

LiPuma, John J., and Terrence L. Stull. "ANTIBACTERIAL AGENTS IN PEDIATRICS." Infectious Disease Clinics of North America 9, no. 3 (1995): 561–74. http://dx.doi.org/10.1016/s0891-5520(20)30686-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Labro, Marie Thérèse. "Immunomodulation by Antibacterial Agents." Drugs 45, no. 3 (1993): 319–28. http://dx.doi.org/10.2165/00003495-199345030-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

&NA;, &NA;. "Antibacterial agents: viral/ parasitic." Current Opinion in Infectious Diseases 9, no. 6 (1996): B235—B251. http://dx.doi.org/10.1097/00001432-199612000-00020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Crunkhorn, Sarah. "Predicting novel antibacterial agents." Nature Reviews Drug Discovery 19, no. 4 (2020): 238. http://dx.doi.org/10.1038/d41573-020-00033-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Melander, Roberta J., Daniel V. Zurawski, and Christian Melander. "Narrow-spectrum antibacterial agents." MedChemComm 9, no. 1 (2018): 12–21. http://dx.doi.org/10.1039/c7md00528h.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

TOTSUKA, KYOICHI. "Pharmacokinetics of antibacterial agents." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 25, no. 1 (1994): 385–87. http://dx.doi.org/10.3999/jscpt.25.385.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Shavely, S. R., and G. R. Hodges. "NEUROTOXICITY OF ANTIBACTERIAL AGENTS." Pediatric Infectious Disease Journal 4, no. 2 (1985): 219. http://dx.doi.org/10.1097/00006454-198503000-00047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

San Joaquin, Venusto H., and Terrence L. Stull. "ANTIBACTERIAL AGENTS IN PEDIATRICS." Infectious Disease Clinics of North America 14, no. 2 (2000): 341–55. http://dx.doi.org/10.1016/s0891-5520(05)70251-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Ford, Charles W., Judith C. Hamel, Douglas Stapert, et al. "Oxazolidinones: New antibacterial agents." Trends in Microbiology 5, no. 5 (1997): 196–200. http://dx.doi.org/10.1016/s0966-842x(97)01032-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Jungheim, L. N., R. J. Ternansky, and R. E. Holmes. "Bicyclic pyrazolidinone antibacterial agents." Drugs of the Future 15, no. 2 (1990): 149. http://dx.doi.org/10.1358/dof.1990.015.02.114554.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Bowlware, Karen L., and Terrence Stull. "Antibacterial agents in pediatrics." Infectious Disease Clinics of North America 18, no. 3 (2004): 513–31. http://dx.doi.org/10.1016/j.idc.2004.04.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Chavez-Bueno, Susana, and Terrence L. Stull. "Antibacterial Agents in Pediatrics." Infectious Disease Clinics of North America 23, no. 4 (2009): 865–80. http://dx.doi.org/10.1016/j.idc.2009.06.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Quesnelle, Claude A., Patrice Gill, Stephan Roy, et al. "Biaryl isoxazolinone antibacterial agents." Bioorganic & Medicinal Chemistry Letters 15, no. 11 (2005): 2728–33. http://dx.doi.org/10.1016/j.bmcl.2005.04.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Meneghetti, Fiorella, and Daniela Barlocco. "Novel Antibacterial Agents 2022." Pharmaceuticals 17, no. 3 (2024): 370. http://dx.doi.org/10.3390/ph17030370.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Gupta, Richa K., Ganesh M. S. Thakuri, Gan B. Bajracharya, and Ram Narayan Jha. "Synthesis of antioxidative anthraquinones as potential anticancer agents." BIBECHANA 18, no. 2 (2021): 143–53. http://dx.doi.org/10.3126/bibechana.v18i2.31234.

Full text

Abstract:

Antioxidant and antibacterial activities of natural anthraquinones namely chrysophanol (1) and emodin (2), and synthesized anthraquinones viz. 2-methylanthraquinone (3), anthraquinone (4), 2-bromoanthraquinone (5), rubiadin (6), chrysophanol diacetate (7), rubiadin diacetate (8) and 1,8-dimethoxy-3-methylanthraquinone (9) were investigated. Anthraquinones 9, 3, 6, 5 and 2 exhibited a high DPPH• radical scavenging capacity (IC50 = <500 μg/mL) showing their therapeutic potentiality for the treatment of cancers. These anthraquinones 1-9 have also displayed a weak to moderate antibacterial acti

APA, Harvard, Vancouver, ISO, and other styles

28

Tavakolian, Mandana, Mira Okshevsky, Theo G. M. van de Ven, and Nathalie Tufenkji. "Developing Antibacterial Nanocrystalline Cellulose Using Natural Antibacterial Agents." ACS Applied Materials & Interfaces 10, no. 40 (2018): 33827–38. http://dx.doi.org/10.1021/acsami.8b08770.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Belete, Tafere Mulaw. "Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents." Human Microbiome Journal 11 (March 2019): 100052. http://dx.doi.org/10.1016/j.humic.2019.01.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Kumaraswamy, D., and D. Prashanth. "SYNTHESIS AND EVALUATION OF PYRAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS." International Journal of Pharmacy and Biological Sciences 7, no. 1 (2017): 84–93. http://dx.doi.org/10.21276/ijpbs.2017.7.1.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Huang, Tianqi, Yusheng Qian, Jia Wei, and Chuncai Zhou. "Polymeric Antimicrobial Food Packaging and Its Applications." Polymers 11, no. 3 (2019): 560. http://dx.doi.org/10.3390/polym11030560.

Full text

Abstract:

Food corruption and spoilage caused by food-borne pathogens and microorganisms is a serious problem. As a result, the demand for antibacterial drugs in food packaging is growing. In this review, biodegradable and non-biodegradable materials for food packaging are discussed based on their properties. Most importantly, antibacterial agents are essential to inhibit the growth of bacteria in food. To keep food fresh and prolong the shelf life, different kinds of antibacterial agents were used. The composition and application of natural antibacterial agents and synthetic antibacterial agents are di

APA, Harvard, Vancouver, ISO, and other styles

32

Hupp, James R. "Antibacterial, Antiviral, and Antifungal Agents." Oral and Maxillofacial Surgery Clinics of North America 3, no. 2 (1991): 273–85. http://dx.doi.org/10.1016/s1042-3699(20)30498-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Livornese, Lawrence L., Mark J. Ingerman, Robert L. Benz, and Jerome Santoro. "ANTIBACTERIAL AGENTS IN RENAL FAILURE." Infectious Disease Clinics of North America 9, no. 3 (1995): 591–614. http://dx.doi.org/10.1016/s0891-5520(20)30688-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Rubino, Christopher M., and John S. Bradley. "Optimizing Therapy with Antibacterial Agents." Pediatric Drugs 9, no. 6 (2007): 361–69. http://dx.doi.org/10.2165/00148581-200709060-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Keniche, Assia, Samia Bellifa, Hafida Hassaine, and Joseph Kajima Mulengi. "Development of new antibacterial agents." Medical Technologies Journal 1, no. 2 (2017): 31–32. http://dx.doi.org/10.26415/2572-004x-vol1iss2p31-32.

Full text

Abstract:

Background: Antibiotics, as miraculous drugs, have been used extensively to confront fatal infection, even without prescriptions. However, the inappropriate and disproportionate use of antibiotics have led to the emergence of new drug-resistant bacteria1, which causes a high risk of serious diseases and dramatically aggravates the clinical complications in hospitals. Methods: By using the peptide coupling protocol, a simple straightforward synthesis of functionalized aziridines has been developed. By means of this synthetic strategy from readily available N-phtaloyl acide and 2-methylben

APA, Harvard, Vancouver, ISO, and other styles

36

Mittapally, Sirisha, Ruheena Taranum, and Sumaiya Parveen. "Metal ions as antibacterial agents." Journal of Drug Delivery and Therapeutics 8, no. 6-s (2018): 411–19. http://dx.doi.org/10.22270/jddt.v8i6-s.2063.

Full text

Abstract:

Metals like mercury, arsenic, copper and silver have been used in various forms as antimicrobials for thousands of years. The use of metals in treatment was mentioned in Ebers Papyrus (1500BC); i.e, copper to decrease inflammation & iron to overcome anemia. Copper has been registered at the U.S. Environmental Protection Agency as the earliest solid antimicrobial material. Copper is used for the treatment of different E. coli, MRSA, Pseudomonas infections. Advantage of use of silver is it has low toxicity to human’s cells than bacteria.It is less susceptible to gram +ve bacteria than gram –

APA, Harvard, Vancouver, ISO, and other styles

37

Kong, Qidi, and Yushe Yang. "Recent advances in antibacterial agents." Bioorganic & Medicinal Chemistry Letters 35 (March 2021): 127799. http://dx.doi.org/10.1016/j.bmcl.2021.127799.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Meneghetti, Fiorella, and Daniela Barlocco. "Special Issue “Novel Antibacterial Agents”." Pharmaceuticals 14, no. 4 (2021): 382. http://dx.doi.org/10.3390/ph14040382.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Wainwright, Nicholas J., Paul Collins, and James Ferguson. "Photosensitivity Associated with Antibacterial Agents." Drug Safety 9, no. 6 (1993): 437–40. http://dx.doi.org/10.2165/00002018-199309060-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Pasquale, T. R., and J. S. Tan. "Nonantimicrobial Effects of Antibacterial Agents." Clinical Infectious Diseases 40, no. 1 (2005): 127–35. http://dx.doi.org/10.1086/426545.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Singal, Anjum, and Gurvinder P. Thami. "Topical Antibacterial Agents in Dermatology." Journal of Dermatology 30, no. 9 (2003): 644–48. http://dx.doi.org/10.1111/j.1346-8138.2003.tb00452.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Balcı, Melin, and Hande Kemaloğlu. "Antibacterial Agents in Restorative Dentistry." Journal of Ege University School of Dentistry 44, no. 3 (2023): 291–99. http://dx.doi.org/10.5505/eudfd.2023.43926.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

&NA;. "Nonantimicrobial Effects of Antibacterial Agents." Pediatric Infectious Disease Journal 24, no. 4 (2005): 395. http://dx.doi.org/10.1097/01.inf.0000159186.41813.c1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Joseph A., Witkowski, and Charles Parish Lawrence. "Cutaneous Reactions to Antibacterial Agents." SKINmed: Dermatology for the Clinician 1, no. 5 (2002): 33–44. http://dx.doi.org/10.1111/j.1540-9740.2002.01856.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Couloigner, Evanne, Dominique Cartier, and Roger Labie. "Synthesis of pyrazolidinone antibacterial agents." Bioorganic & Medicinal Chemistry Letters 9, no. 15 (1999): 2205–6. http://dx.doi.org/10.1016/s0960-894x(99)00352-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Thorarensen, Atli, Gary E. Zurenko, Michael T. Sweeney, Keith R. Marotti, and Timothy P. Boyle. "Enols as Potent Antibacterial Agents." Bioorganic & Medicinal Chemistry Letters 11, no. 22 (2001): 2931–34. http://dx.doi.org/10.1016/s0960-894x(01)00587-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Chen, Luke F., Teena Chopra, and Keith S. Kaye. "Pathogens Resistant to Antibacterial Agents." Medical Clinics of North America 95, no. 4 (2011): 647–76. http://dx.doi.org/10.1016/j.mcna.2011.03.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kaye, Keith S., and Donald Kaye. "Antibacterial Therapy and Newer Agents." Medical Clinics of North America 95, no. 4 (2011): xi—xii. http://dx.doi.org/10.1016/j.mcna.2011.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Labro, Marie Thérèse. "Immunomodulatory Actions of Antibacterial Agents." Clinical Immunotherapeutics 6, no. 6 (1996): 454–64. http://dx.doi.org/10.1007/bf03259367.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Kern, Thomas J. "Antibacterial agents for ocular therapeutics." Veterinary Clinics of North America: Small Animal Practice 34, no. 3 (2004): 655–68. http://dx.doi.org/10.1016/j.cvsm.2003.12.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!